science

Italy’s Eni SpA cut pump prices for at least a month, offering some respite for Prime Minister Giorgia Meloni, who is trying to shield consumers from spiraling costs ahead of a general election next year.

People are being spotted emerging from New York City's sewers, generating wild theories online about their intentions. (Source: Bloomberg)

DALLAS--(BUSINESS WIRE)--Generational Group announces the sale of Interstate Threaded Products, a supplier of high-quality threaded fasteners to a private investment firm.

The wave of regulatory tightening in India’s derivatives market is largely complete, says NSE CEO Ashishkumar Chauhan. In a conversation with BTV, he adds that the exchange is beginning to regain market share in the F&O space. (Source: Bloomberg)

The more details that emerge about the agreement to settle an antitrust lawsuit that would’ve blocked Paramount Skydance’s $111 billion acquisition of Warner Bros. Discovery, the more blame has been heaped on one man: California Attorney General Rob Bonta.

Adarx Pharmaceuticals Inc., a late-stage developer of gene therapies, raised $446.3 million in an upsized initial public offering that priced at the top of its marketed range.

The more details that emerge about the agreement to settle an antitrust lawsuit that would’ve blocked Paramount Skydance’s $111 billion acquisition of Warner Bros. Discovery, the more blame has been heaped on one man: California Attorney General Rob Bonta.

Glass Lewis & Co. is merging with European-focused ESG data and analytics firm Clarity AI, as the proxy adviser expands its footprint in a market where investor demand for managing climate and sustainability risks are on the rise.

VANCOUVER, British Columbia, Sept. 23, 2026 (GLOBE NEWSWIRE) -- Zymeworks Inc. (Nasdaq: ZYME), a biotechnology company managing a portfolio of licensed healthcare assets while developing a diverse pipeline of novel, multifunctional biotherapeutics, today completed the previously announced acquisitio

VANCOUVER, British Columbia, Sept. 23, 2026 (GLOBE NEWSWIRE) -- Zymeworks Inc. (Nasdaq: ZYME), a biotechnology company managing a portfolio of licensed healthcare assets while developing a diverse pipeline of novel, multifunctional biotherapeutics, today completed the previously announced acquisitio